CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- 4 Open-market sale Chief Medical Officer sold 919 shares at $15.00 ($13,785)
- 4 Open-market sale See Remarks sold 4,392 shares at $15.10 ($66,319)
- 4 Open-market sale Chief Medical Officer sold 21,669 shares at $15.00 ($325,035)
- 4 Open-market sale Chief Scientific Officer sold 7,500 shares at an average $13.00 ($97,520)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $12.00 ($60,000)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $10.67 ($53,334)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $10.01 ($50,064)
- 4 Open-market sale Chief Scientific Officer sold 1,656 shares at $12.00 ($19,872)
- 4 Open-market sale Chief Scientific Officer sold 844 shares at $12.00 ($10,128)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $10.11 ($50,531)
- 4 Open-market sale Chief Scientific Officer sold 7,500 shares at an average $13.42 ($100,631)
- 4 Open-market sale Chief Scientific Officer sold 7,500 shares at an average $14.40 ($107,983)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Business Officer sold 5,415 shares at $16.07 ($87,019)
- 4 Open-market sale See Remarks sold 14,000 shares at an average $15.11 ($211,523)
- 4 Open-market sale Chief Scientific Officer sold 7,500 shares at $13.90 ($104,267)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 15 · 290 filings